Walgreens Boots Alliance Inc. (WBA) Stake Raised by BlackRock Group LTD

Walgreens Boots Alliance Inc. (WBA) Stake Raised by BlackRock Group LTD

BlackRock Group LTD boosted its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 2.5% during the third quarter, Holdings Channel reports. The fund owned 7,560,651 shares of the pharmacy operator’s stock after buying an additional 182,237 shares during the period. BlackRock Group LTD’s holdings in Walgreens Boots Alliance were worth $609,541,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB boosted its position in shares of Walgreens Boots Alliance by 4,480.8% in the third quarter. Nordea Investment Management AB now owns 7,453,892 shares of the pharmacy operator’s stock worth $600,933,000 after buying an additional 7,291,172 shares in the last quarter. Boston Partners boosted its position in Walgreens Boots Alliance by 5,790.4% in the second quarter. Boston Partners now owns 3,158,410 shares of the pharmacy operator’s stock valued at $263,001,000 after buying an additional 3,104,790 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its position in Walgreens Boots Alliance by 60.1% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,525,003 shares of the pharmacy operator’s stock valued at $626,607,000 after buying an additional 2,825,700 shares during the period. Capital World Investors boosted its position in Walgreens Boots Alliance by 11.5% in the second quarter. Capital World Investors now owns 19,625,115 shares of the pharmacy operator’s stock valued at $1,634,183,000 after buying an additional 2,028,252 shares during the period. Finally, Sound Shore Management Inc. CT acquired a new position in Walgreens Boots Alliance during the third quarter valued at $163,288,000. 59.05% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) opened at 84.49 on Wednesday. The company has a market capitalization of $91.53 billion, a PE ratio of 22.12 and a beta of 1.19. The stock’s 50 day moving average price is $84.39 and its 200-day moving average price is $82.16. Walgreens Boots Alliance Inc. has a 52-week low of $71.50 and a 52-week high of $102.82.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.08. The business earned $28.60 billion during the quarter, compared to the consensus estimate of $29.06 billion. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. Walgreens Boots Alliance’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the company earned $0.88 earnings per share. On average, analysts expect that Walgreens Boots Alliance Inc. will post $5.02 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, December 12th. Shareholders of record on Thursday, November 17th were paid a $0.375 dividend. The ex-dividend date was Tuesday, November 15th. This represents a $1.50 dividend on an annualized basis and a yield of 1.78%. Walgreens Boots Alliance’s dividend payout ratio is 39.27%.

Several equities analysts have weighed in on WBA shares. Bank of America Corp. reaffirmed a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. Deutsche Bank AG lifted their target price on Walgreens Boots Alliance from $93.00 to $94.00 and gave the company a “buy” rating in a research note on Tuesday, August 30th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, October 3rd. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a research note on Monday, October 3rd. Finally, Jefferies Group raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and lifted their target price for the company from $87.00 to $95.00 in a research note on Monday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $90.30.

In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 5,700 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $85.05, for a total value of $484,785.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Stefano Pessina purchased 2,000,000 shares of the firm’s stock in a transaction on Friday, November 4th. The stock was bought at an average price of $81.41 per share, with a total value of $162,820,000.00. The disclosure for this purchase can be found here. 13.50% of the stock is owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc. (NASDAQ:WBA).

Related posts

Leave a Comment